Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1B1 | Q16678 | 6/20 | 0.91 |
| ▸ | MAPT | P10636 | 5/20 | 0.91 |
| ▸ | MAOB | P27338 | 4/20 | 0.91 |
| ▸ | BCHE | P06276 | 3/20 | 0.91 |
| ▸ | LMNA | P02545 | 2/20 | 0.91 |
| ▸ | PLIN1 | O60240 | 1/20 | 0.91 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.91 |
| ▸ | ACHE | P22303 | 1/20 | 0.91 |
| ▸ | RECQL | P46063 | 1/20 | 0.91 |
| ▸ | PLIN5 | Q00G26 | 1/20 | 0.91 |
| ▸ | ABHD5 | Q8WTS1 | 1/20 | 0.91 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.85 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.85 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.85 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.85 |
| ▸ | RELA | Q04206 | 2/20 | 0.85 |
| ▸ | HSPD1 | P10809 | 2/20 | 0.85 |
| ▸ | HSPE1 | P61604 | 2/20 | 0.85 |
| ▸ | RAB9A | P51151 | 2/20 | 0.85 |
| ▸ | PKM | P14618 | 1/20 | 0.85 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8431772 | 1.00 | CYP1B1 (0.91) | CYP1B1MAPTMAOBBCHELMNA | |
| Chalcone SCHEMBL28306720 | 0.95 | CYP1B1 (1.00) | CYP1B1MAPTMAOBBCHELMNA | |
| Chalcone SCHEMBL29922932 | 0.95 | CYP1B1 (1.00) | CYP1B1MAPTMAOBBCHELMNA | |
| Chalcone SCHEMBL27581 | 0.95 | CYP1B1 (1.00) | CYP1B1MAPTMAOBBCHELMNA | |
| Chalcone SCHEMBL2404758 | 0.95 | CYP1B1 (1.00) | CYP1B1MAPTMAOBBCHELMNA | |
| Chalcone SCHEMBL27580 | 0.95 | CYP1B1 (1.00) | CYP1B1MAPTMAOBBCHELMNA | |
| Chalcone SCHEMBL29396001 | 0.95 | CYP1B1 (1.00) | CYP1B1MAPTMAOBBCHELMNA | |
| Chalcone SCHEMBL454583 | 0.95 | CYP1B1 (1.00) | CYP1B1MAPTMAOBBCHELMNA | |
| SCHEMBL25193884 | 0.94 | CYP1B1 (0.81) | CYP1B1MAPTMAOBBCHELMNA | |
| SCHEMBL13680426 | 0.94 | CYP1B1 (0.81) | CYP1B1MAPTMAOBBCHELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2164826-B1 | DENDRITIC PHOTOACTIVE COMPOUND COMPRISING OXIME ESTER AND METHOD FOR PREPARING THE SAME | LG CHEMICAL LTD (KR) | 2013-04-03 | — | — | EP | disclosed |
| US-8198462-B2 | Dendritic photoactive compound comprising oxime ester and method for preparing the same | LG CHEM, LTD. (KR) | 2012-06-12 | — | — | US | disclosed |
| US-8198462-B2 | Dendritic photoactive compound comprising oxime ester and method for preparing the same | LG CHEM, LTD. (KR) | 2012-06-12 | — | — | US | disclosed |
| US-20100145068-A1 | Dendritic Photoactive Compound Comprising Oxime Ester And Method For Preparing The Same | LG CHEM, LTD. (KR) | 2010-06-10 | — | — | US | disclosed |
| US-20100145068-A1 | Dendritic Photoactive Compound Comprising Oxime Ester And Method For Preparing The Same | LG CHEM, LTD. (KR) | 2010-06-10 | — | — | US | disclosed |
| US-7582364-B2 | Utilizing phosphorescence which emits light efficiently with high luminance at low current density; flat panel displays | NIPPON STEEL CHEMICAL CO., LTD. (JP) | 2009-09-01 | — | — | US | disclosed |
| US-7582364-B2 | Utilizing phosphorescence which emits light efficiently with high luminance at low current density; flat panel displays | NIPPON STEEL CHEMICAL CO., LTD. (JP) | 2009-09-01 | — | — | US | disclosed |
| WO-2009011538-A2 | DENDRITIC PHOTOACTIVE COMPOUND COMPRISING OXIME ESTER AND METHOD FOR PREPARING THE SAME | LG CHEM, LTD. (KR) | 2009-01-22 | — | — | WO | disclosed |
| US-20070012935-A1 | Organic electroluminescent device | NIPPON STEEL CHEMICAL CO., LTD. (JP) | 2007-01-18 | — | — | US | disclosed |
| US-20070012935-A1 | Organic electroluminescent device | NIPPON STEEL CHEMICAL CO., LTD. (JP) | 2007-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100145068-A1 | Dendritic Photoactive Compound Comprising Oxime Ester And Method For Preparing The Same | PPOX, OXER1, TLR7 | CYP1B1 2436/4885MAPT 612/4885MAOB 260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.